Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kleyn

Showing results (141-150 of 198) with videos related to

Pageof 20
Sort By:
Human Molecular Genetics|August 1, 1993
High resolution physical map of the region surrounding the spinal muscular atrophy geneT G Thompson, K E Morrison, P Kleyn, et al.
European Journal of Dermatology : EJD|October 27, 2022
Improvement of head and neck symptoms in patients with atopic dermatitis treated with baricitinib based on five Phase III clinical trialsAndreas Wollenberg, Peter Lio, Elise Kleyn, et al.
Molecules (Basel, Switzerland)|May 19, 2019
Current Mechanistic and Pharmacodynamic Understanding of Melanocortin-4 Receptor ActivationShubh Sharma, Alastair S Garfield, Bhavik Shah, et al.
JAMA Dermatology|June 7, 2023
Fertility Trends and Adverse Pregnancy Outcomes in Female Patients With Psoriasis in the UKTeng-Chou Chen, Ireny Y K Iskandar, Rosa Parisi, et al.
Journal of Hepatology|November 13, 2020
Hepatotoxicity following administration of onasemnogene abeparvovec (AVXS-101) for the treatment of spinal muscular atrophyDeepa Chand, Franziska Mohr, Hugh McMillan, et al.
The British Journal of Dermatology|January 22, 2022
How do dermatologists' personal models inform a patient-centred approach to management: a qualitative study using the example of prescribing a new treatment (Apremilast)Rachael M Hewitt, Chris Bundy, Antonia-Luise Newi, et al.
Dermatology and Therapy|January 29, 2025
Baricitinib Provides Significant Improvements in Quality of Life and Functioning in Adults with Moderate-to-Severe Atopic Dermatitis with Baseline Body Surface Area ≤ 40% and Severe ItchMatthias Augustin, Maddalena Napolitano, Rosa Izu-Belloso, et al.
International Urogynecology Journal|November 20, 2012
Guidelines for the management of third and fourth degree perineal tears after vaginal birth from the Austrian Urogynecology Working GroupT Aigmueller, W Umek, K Elenskaia, et al.
Future Healthcare Journal|July 22, 2025
Enhancing mental health resilience in the healthcare workforce during COVID-19: lessons from The North West OfferGeorgia Lada, Amy L Rathbone, Andy Coley, et al.
The British Journal of Dermatology|February 24, 2012
The British Association of Dermatologists' Biologic Interventions Register (BADBIR): design, methodology and objectivesA D Burden, R B Warren, C E Kleyn, et al.
Pageof 20

Showing results (141-150 of 198) with videos related to

Sort By:
Pageof 20
Human Molecular Genetics|August 1, 1993
High resolution physical map of the region surrounding the spinal muscular atrophy geneT G Thompson, K E Morrison, P Kleyn, et al.
European Journal of Dermatology : EJD|October 27, 2022
Improvement of head and neck symptoms in patients with atopic dermatitis treated with baricitinib based on five Phase III clinical trialsAndreas Wollenberg, Peter Lio, Elise Kleyn, et al.
Molecules (Basel, Switzerland)|May 19, 2019
Current Mechanistic and Pharmacodynamic Understanding of Melanocortin-4 Receptor ActivationShubh Sharma, Alastair S Garfield, Bhavik Shah, et al.
JAMA Dermatology|June 7, 2023
Fertility Trends and Adverse Pregnancy Outcomes in Female Patients With Psoriasis in the UKTeng-Chou Chen, Ireny Y K Iskandar, Rosa Parisi, et al.
Journal of Hepatology|November 13, 2020
Hepatotoxicity following administration of onasemnogene abeparvovec (AVXS-101) for the treatment of spinal muscular atrophyDeepa Chand, Franziska Mohr, Hugh McMillan, et al.
The British Journal of Dermatology|January 22, 2022
How do dermatologists' personal models inform a patient-centred approach to management: a qualitative study using the example of prescribing a new treatment (Apremilast)Rachael M Hewitt, Chris Bundy, Antonia-Luise Newi, et al.
Dermatology and Therapy|January 29, 2025
Baricitinib Provides Significant Improvements in Quality of Life and Functioning in Adults with Moderate-to-Severe Atopic Dermatitis with Baseline Body Surface Area ≤ 40% and Severe ItchMatthias Augustin, Maddalena Napolitano, Rosa Izu-Belloso, et al.
International Urogynecology Journal|November 20, 2012
Guidelines for the management of third and fourth degree perineal tears after vaginal birth from the Austrian Urogynecology Working GroupT Aigmueller, W Umek, K Elenskaia, et al.
Future Healthcare Journal|July 22, 2025
Enhancing mental health resilience in the healthcare workforce during COVID-19: lessons from The North West OfferGeorgia Lada, Amy L Rathbone, Andy Coley, et al.
The British Journal of Dermatology|February 24, 2012
The British Association of Dermatologists' Biologic Interventions Register (BADBIR): design, methodology and objectivesA D Burden, R B Warren, C E Kleyn, et al.
Pageof 20